All pharmaceutical companies in China are required by SFDA to gain GMP certificate, which is valid for five years, for the production of pharmaceuticals.
Huifeng Bio-Pharmaceutical is a developer and producer of botanical extracts and other raw materials for pharmaceuticals and food additives.
Huifeng Bio-Pharmaceutical CEO Jing’an Wang said that the approval of GMP certificate has a significant impact on the company’s future success and further proves the superior quality standards of their products.
“This certification allows us to move forward to expand not only our domestic market but also our oversea markets, such as in U.S., India, European countries, Japan and South America as GMP is required by their government,” Wang said.